Lauren Granillo1, Sunjay Sethi2, Kimberly P Keil2, Yanping Lin2, Sally Ozonoff3, Ana-Maria Iosif4, Birgit Puschner2, Rebecca J Schmidt5. 1. Graduate Group in Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA. Electronic address: lpgranillo@ucdavis.edu. 2. Department of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA. 3. MIND Institute, School of Medicine, University of California, Davis, Sacramento, CA, USA; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California Davis, Sacramento, CA, USA. 4. Department of Public Health Sciences, School of Medicine, University of California, Davis, Davis, CA, USA. 5. MIND Institute, School of Medicine, University of California, Davis, Sacramento, CA, USA; Department of Public Health Sciences, School of Medicine, University of California, Davis, Davis, CA, USA.
Abstract
BACKGROUND: Autism spectrum disorder (ASD) is suspected to have environmental and genetic contributions. Polychlorinated biphenyls (PCBs) are environmental risk factors of interest due to their potential as neurodevelopmental toxicants and environmental persistence despite a US production ban in the 1970s. METHODS: Participants were mother-child pairs from MARBLES, a high-risk pregnancy cohort that enrolls families who have one child diagnosed with ASD and are planning to have another child. PCB concentrations were measured in maternal blood at each trimester of pregnancy using gas chromatography coupled with triple quadruple mass spectrometry. Concentrations were summed into total PCB and two categories based on function/mechanisms of action: dioxin-like (DL), and ryanodine receptor (RyR)-activating PCBs. Multinomial logistic regression assessed risk of clinical outcome classification of ASD and non-typical development (Non-TD) compared to typically developing (TD) in the children at 3 years old. RESULTS: A total of 104 mother-child pairs were included. There were no significant associations for total PCB; however, there were borderline significant associations between DL-PCBs and decreased risk for Non-TD outcome classification (adjusted OR: 0.41 (95% CI 0.15-1.14)) and between RyR-activating PCBs and increased risk for ASD outcome classification (adjusted OR: 2.63 (95% CI 0.87-7.97)). CONCLUSION: This study does not provide strong supporting evidence that PCBs are risk factors for ASD or Non-TD. However, these analyses suggest the need to explore more deeply into subsets of PCBs as risk factors based on their function and structure in larger cohort studies where non-monotonic dose-response patterns can be better evaluated.
BACKGROUND:Autism spectrum disorder (ASD) is suspected to have environmental and genetic contributions. Polychlorinated biphenyls (PCBs) are environmental risk factors of interest due to their potential as neurodevelopmental toxicants and environmental persistence despite a US production ban in the 1970s. METHODS:Participants were mother-child pairs from MARBLES, a high-risk pregnancy cohort that enrolls families who have one child diagnosed with ASD and are planning to have another child. PCB concentrations were measured in maternal blood at each trimester of pregnancy using gas chromatography coupled with triple quadruple mass spectrometry. Concentrations were summed into total PCB and two categories based on function/mechanisms of action: dioxin-like (DL), and ryanodine receptor (RyR)-activating PCBs. Multinomial logistic regression assessed risk of clinical outcome classification of ASD and non-typical development (Non-TD) compared to typically developing (TD) in the children at 3 years old. RESULTS: A total of 104 mother-child pairs were included. There were no significant associations for total PCB; however, there were borderline significant associations between DL-PCBs and decreased risk for Non-TD outcome classification (adjusted OR: 0.41 (95% CI 0.15-1.14)) and between RyR-activating PCBs and increased risk for ASD outcome classification (adjusted OR: 2.63 (95% CI 0.87-7.97)). CONCLUSION: This study does not provide strong supporting evidence that PCBs are risk factors for ASD or Non-TD. However, these analyses suggest the need to explore more deeply into subsets of PCBs as risk factors based on their function and structure in larger cohort studies where non-monotonic dose-response patterns can be better evaluated.
Authors: Kinga Lancz; Lubica Murínová; Henrieta Patayová; Beata Drobná; Soňa Wimmerová; Eva Sovčíková; Ján Kováč; Dana Farkašová; Irva Hertz-Picciotto; Todd A Jusko; Tomáš Trnovec Journal: Int J Hyg Environ Health Date: 2014-09-06 Impact factor: 5.840
Authors: Rachel F Marek; Peter S Thorne; Nicholas J Herkert; Andrew M Awad; Keri C Hornbuckle Journal: Environ Sci Technol Date: 2017-06-28 Impact factor: 9.028
Authors: MacKinsey A Bach; Maureen Samms-Vaughan; Manouchehr Hessabi; Jan Bressler; MinJae Lee; Jing Zhang; Sydonnie Shakespeare-Pellington; Megan L Grove; Katherine A Loveland; Mohammad H Rahbar Journal: Res Autism Spectr Disord Date: 2020-06-18
Authors: Talia E Gileadi; Abhyuday K Swamy; Zoe Hore; Stuart Horswell; Jacob Ellegood; Conor Mohan; Keiko Mizuno; Anne-Katrine Lundebye; K Peter Giese; Brigitta Stockinger; Christer Hogstrand; Jason P Lerch; Cathy Fernandes; M Albert Basson Journal: Environ Health Perspect Date: 2021-05-06 Impact factor: 9.031